glp 1 updates KFF's latest Health Tracking Poll provides an update to last year's poll measuring public use of GLP-1 agonists — a class of drugs that includes brand names like Ozempic and Wegovy often Glucagon-like peptide-1 receptor: mechanisms and
Description
The tension between semaglutides and body acceptance is palpable

Tissue Barriers 12:2292461

Front Immunol (2022) 13:864007
Experimental studies have shown that GLP-1 RAs can reverse early retinal changes associated with DR, restoring blood-retinal barrier integrity and preventing retinal cell death

High heart rate: a cardiovascular risk factor

Dose changes may contribute to side effects
